JP2009542723A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009542723A5 JP2009542723A5 JP2009518636A JP2009518636A JP2009542723A5 JP 2009542723 A5 JP2009542723 A5 JP 2009542723A5 JP 2009518636 A JP2009518636 A JP 2009518636A JP 2009518636 A JP2009518636 A JP 2009518636A JP 2009542723 A5 JP2009542723 A5 JP 2009542723A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydroxy
- piperazin
- cyclopenta
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 202
- -1 CH 2 F Chemical compound 0.000 claims description 172
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 44
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 41
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 32
- 125000000623 heterocyclic group Chemical group 0.000 claims description 30
- 125000004429 atom Chemical group 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 24
- 229910052736 halogen Chemical group 0.000 claims description 23
- 125000003386 piperidinyl group Chemical group 0.000 claims description 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 22
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 21
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 18
- 229910052731 fluorine Inorganic materials 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 14
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 13
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 13
- 125000002883 imidazolyl group Chemical group 0.000 claims description 13
- 125000002757 morpholinyl group Chemical group 0.000 claims description 13
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 12
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 12
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 10
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 9
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 9
- 239000002207 metabolite Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims description 9
- 239000012453 solvate Substances 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 claims description 7
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 6
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 5
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 5
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 5
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 5
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 5
- 125000004864 4-thiomethylphenyl group Chemical group 0.000 claims description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 4
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims description 4
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 claims description 4
- 125000002393 azetidinyl group Chemical group 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000003566 oxetanyl group Chemical group 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 229930192474 thiophene Natural products 0.000 claims description 3
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 15
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical compound CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 claims 6
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims 4
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- UVHCRURXEOGIOT-YHYVQYDKSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NC1CCOCC1 UVHCRURXEOGIOT-YHYVQYDKSA-N 0.000 claims 2
- GPXSIDKEQZLUST-YSZBQJHXSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[methyl(oxan-4-yl)amino]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N(C)C1CCOCC1 GPXSIDKEQZLUST-YSZBQJHXSA-N 0.000 claims 2
- IDKRIUJFWDXJFA-ZIAGYGMSSA-N 1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1CN(C(=O)CCNC(C)C)CCN1C1=NC=NC2=C1[C@H](C)C[C@H]2O IDKRIUJFWDXJFA-ZIAGYGMSSA-N 0.000 claims 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 2
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- GRZXWCHAXNAUHY-NSISKUIASA-N (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]-1-piperazinyl]-3-(propan-2-ylamino)-1-propanone Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C=C1 GRZXWCHAXNAUHY-NSISKUIASA-N 0.000 claims 1
- AGKRBOABBMQFSL-SZVBFZGTSA-N (2r)-2-(5-bromopyridin-2-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Br)C=N1 AGKRBOABBMQFSL-SZVBFZGTSA-N 0.000 claims 1
- PSFGVYMXTXICGR-ZPMCFJSWSA-N (2s)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)-2-[4-(trifluoromethyl)phenyl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(=CC=1)C(F)(F)F)NC1CCOCC1 PSFGVYMXTXICGR-ZPMCFJSWSA-N 0.000 claims 1
- XPLGOANHGFSMIB-NSISKUIASA-N (2s)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)-2-[4-(trifluoromethoxy)phenyl]propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(OC(F)(F)F)C=C1 XPLGOANHGFSMIB-NSISKUIASA-N 0.000 claims 1
- PSFGVYMXTXICGR-YHYVQYDKSA-N (2s)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)-2-[4-(trifluoromethyl)phenyl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(=CC=1)C(F)(F)F)NC1CCOCC1 PSFGVYMXTXICGR-YHYVQYDKSA-N 0.000 claims 1
- RFVHSXAEGORYON-WRWLIDTKSA-N (2s)-2-(3,4-dichlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C(Cl)=C1 RFVHSXAEGORYON-WRWLIDTKSA-N 0.000 claims 1
- QSBNMLHJMWKHPC-PERKRYKHSA-N (2s)-2-(3,4-dichlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(Cl)C(Cl)=CC=1)NC1CCOCC1 QSBNMLHJMWKHPC-PERKRYKHSA-N 0.000 claims 1
- RFVHSXAEGORYON-MDYRTPRTSA-N (2s)-2-(3,4-dichlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C(Cl)=C1 RFVHSXAEGORYON-MDYRTPRTSA-N 0.000 claims 1
- PWOQUDDUGDELMH-YVWKXTFCSA-N (2s)-2-(3-bromo-4-methoxyphenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1=C(Br)C(OC)=CC=C1[C@@H](CNC(C)C)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 PWOQUDDUGDELMH-YVWKXTFCSA-N 0.000 claims 1
- SWWHWGUJQDFXIK-CDHQVMDDSA-N (2s)-2-(3-chloro-5-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC(F)=CC(Cl)=C1 SWWHWGUJQDFXIK-CDHQVMDDSA-N 0.000 claims 1
- MUXRDILUGIICGM-YVWKXTFCSA-N (2s)-2-(3-fluoro-4-methoxyphenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1=C(F)C(OC)=CC=C1[C@@H](CNC(C)C)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 MUXRDILUGIICGM-YVWKXTFCSA-N 0.000 claims 1
- DFIROWVISDLYGD-BSLALVQMSA-N (2s)-2-(4-bromo-2-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C(=CC(Br)=CC=1)F)NC1CCOCC1 DFIROWVISDLYGD-BSLALVQMSA-N 0.000 claims 1
- BZFDVHZRSWYZDK-ZTNFWEORSA-N (2s)-2-(4-bromo-2-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Br)C=C1F BZFDVHZRSWYZDK-ZTNFWEORSA-N 0.000 claims 1
- FTWBLDCYUPIIAY-VMRPVKRXSA-N (2s)-2-(4-bromo-2-fluorophenyl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C(=CC(Br)=CC=1)F)NCC1CC1 FTWBLDCYUPIIAY-VMRPVKRXSA-N 0.000 claims 1
- OCQNQFLNELAMDZ-PERKRYKHSA-N (2s)-2-(4-bromo-3-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(Br)=CC=1)NC1CCOCC1 OCQNQFLNELAMDZ-PERKRYKHSA-N 0.000 claims 1
- XVEXKPVULYSHJA-MDYRTPRTSA-N (2s)-2-(4-bromo-3-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Br)C(F)=C1 XVEXKPVULYSHJA-MDYRTPRTSA-N 0.000 claims 1
- HFGKNCISXBYAHW-FPDPHYFHSA-N (2s)-2-(4-bromo-3-fluorophenyl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(Br)=CC=1)NCC1CC1 HFGKNCISXBYAHW-FPDPHYFHSA-N 0.000 claims 1
- WVIZRBIXJGGNIL-ZPMCFJSWSA-N (2s)-2-(4-bromophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(4-hydroxypiperidin-1-yl)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Br)=CC=1)N1CCC(O)CC1 WVIZRBIXJGGNIL-ZPMCFJSWSA-N 0.000 claims 1
- FOQONSLSQMXHLK-AGILITTLSA-N (2s)-2-(4-bromophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(4-propan-2-ylpiperazin-1-yl)propan-1-one Chemical compound C1CN(C(C)C)CCN1C[C@H](C=1C=CC(Br)=CC=1)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 FOQONSLSQMXHLK-AGILITTLSA-N 0.000 claims 1
- PUPXZZLGFLTHDO-DUXKGJEZSA-N (2s)-2-(4-bromophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[methyl(propan-2-yl)amino]propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CN(C)C(C)C)=CC=C(Br)C=C1 PUPXZZLGFLTHDO-DUXKGJEZSA-N 0.000 claims 1
- SNDIBRJFLLYGDF-YHYVQYDKSA-N (2s)-2-(4-bromophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Br)=CC=1)NC1CCOCC1 SNDIBRJFLLYGDF-YHYVQYDKSA-N 0.000 claims 1
- GGGQLFZGNGYUKR-AHRSYUTCSA-N (2s)-2-(4-bromophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Br)C=C1 GGGQLFZGNGYUKR-AHRSYUTCSA-N 0.000 claims 1
- PUPXZZLGFLTHDO-UIFIKXQLSA-N (2s)-2-(4-bromophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[methyl(propan-2-yl)amino]propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CN(C)C(C)C)=CC=C(Br)C=C1 PUPXZZLGFLTHDO-UIFIKXQLSA-N 0.000 claims 1
- WPELGIJMNKTPIX-HBGVWJBISA-N (2s)-2-(4-bromophenyl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Br)=CC=1)NCC1CC1 WPELGIJMNKTPIX-HBGVWJBISA-N 0.000 claims 1
- HSOGRIPRDLRNDR-NSISKUIASA-N (2s)-2-(4-bromophenyl)-3-(tert-butylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CNC(C)(C)C)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(Br)C=C1 HSOGRIPRDLRNDR-NSISKUIASA-N 0.000 claims 1
- QKNAUPPDBNDABJ-OTDDCGGZSA-N (2s)-2-(4-bromophenyl)-3-[(3,3-dimethylcyclohexyl)amino]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Br)=CC=1)NC1CCCC(C)(C)C1 QKNAUPPDBNDABJ-OTDDCGGZSA-N 0.000 claims 1
- LXYGYMUEGJOHPL-CTUHWIOQSA-N (2s)-2-(4-bromophenyl)-3-[(4,4-dimethylcyclohexyl)amino]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Br)=CC=1)NC1CCC(C)(C)CC1 LXYGYMUEGJOHPL-CTUHWIOQSA-N 0.000 claims 1
- XWUHJIRBJMLAJN-YHYVQYDKSA-N (2s)-2-(4-bromophenyl)-3-[cyclopropylmethyl(methyl)amino]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Br)=CC=1)N(C)CC1CC1 XWUHJIRBJMLAJN-YHYVQYDKSA-N 0.000 claims 1
- ZTYJPNKNJIXMLC-BSLALVQMSA-N (2s)-2-(4-chloro-2-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C(=CC(Cl)=CC=1)F)NC1CCOCC1 ZTYJPNKNJIXMLC-BSLALVQMSA-N 0.000 claims 1
- NCSAHEXYKZKHST-XFQXTVEOSA-N (2s)-2-(4-chloro-2-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C=C1F NCSAHEXYKZKHST-XFQXTVEOSA-N 0.000 claims 1
- ZTYJPNKNJIXMLC-CNDZOEFASA-N (2s)-2-(4-chloro-2-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C(=CC(Cl)=CC=1)F)NC1CCOCC1 ZTYJPNKNJIXMLC-CNDZOEFASA-N 0.000 claims 1
- SVXUNOUHNODYLE-QFIXIFRTSA-N (2s)-2-(4-chloro-2-fluorophenyl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C(=CC(Cl)=CC=1)F)NCC1CC1 SVXUNOUHNODYLE-QFIXIFRTSA-N 0.000 claims 1
- VDABUDNQDPCQIC-HGHGUNKESA-N (2s)-2-(4-chloro-3-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(2-methylpropylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNCC(C)C)=CC=C(Cl)C(F)=C1 VDABUDNQDPCQIC-HGHGUNKESA-N 0.000 claims 1
- PSNRYUGYGZTZSY-PERKRYKHSA-N (2s)-2-(4-chloro-3-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(Cl)=CC=1)NC1CCOCC1 PSNRYUGYGZTZSY-PERKRYKHSA-N 0.000 claims 1
- YCWGOSQFOZHSQF-ZWDAVXSWSA-N (2s)-2-(4-chloro-3-fluorophenyl)-3-(cyclopentylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=C(F)C(Cl)=CC=1)NC1CCCC1 YCWGOSQFOZHSQF-ZWDAVXSWSA-N 0.000 claims 1
- CHZXOMCJYQFHSX-HCLVMJGWSA-N (2s)-2-(4-chloro-3-fluorophenyl)-3-(cyclopentylmethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=C(F)C(Cl)=CC=1)NCC1CCCC1 CHZXOMCJYQFHSX-HCLVMJGWSA-N 0.000 claims 1
- DACYNDHEVFUCHW-STZQEDGTSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(1,4-oxazepan-4-yl)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCCOCC1 DACYNDHEVFUCHW-STZQEDGTSA-N 0.000 claims 1
- BDKRQVSZTNVSIM-MAODMQOUSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(3-methoxyazetidin-1-yl)propan-1-one Chemical compound C1C(OC)CN1C[C@H](C=1C=CC(Cl)=CC=1)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 BDKRQVSZTNVSIM-MAODMQOUSA-N 0.000 claims 1
- MVKDZJLQKKHGGJ-ZPMCFJSWSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(4-hydroxypiperidin-1-yl)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCC(O)CC1 MVKDZJLQKKHGGJ-ZPMCFJSWSA-N 0.000 claims 1
- NHOOVUOOHFQRHO-SXSPYAJSSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(4-methoxypiperidin-1-yl)propan-1-one Chemical compound C1CC(OC)CCN1C[C@H](C=1C=CC(Cl)=CC=1)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 NHOOVUOOHFQRHO-SXSPYAJSSA-N 0.000 claims 1
- JKUFKXQNEFTSBQ-AGILITTLSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(4-propan-2-ylpiperazin-1-yl)propan-1-one Chemical compound C1CN(C(C)C)CCN1C[C@H](C=1C=CC(Cl)=CC=1)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 JKUFKXQNEFTSBQ-AGILITTLSA-N 0.000 claims 1
- OMFKFXBPXIIGLQ-ZTFGCOKTSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(methoxyamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNOC)=CC=C(Cl)C=C1 OMFKFXBPXIIGLQ-ZTFGCOKTSA-N 0.000 claims 1
- AKFVQBJAJZYJNS-SXSPYAJSSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[4-(methylamino)piperidin-1-yl]propan-1-one Chemical compound C1CC(NC)CCN1C[C@H](C=1C=CC(Cl)=CC=1)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 AKFVQBJAJZYJNS-SXSPYAJSSA-N 0.000 claims 1
- ZAPKSMBFGRLTBZ-QYRPDUKASA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[[(3r)-oxolan-3-yl]amino]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N[C@@H]1CCOC1 ZAPKSMBFGRLTBZ-QYRPDUKASA-N 0.000 claims 1
- AQZUYEHYCSSTOS-QYRPDUKASA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[[(3r)-pyrrolidin-3-yl]amino]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N[C@@H]1CCNC1 AQZUYEHYCSSTOS-QYRPDUKASA-N 0.000 claims 1
- AQZUYEHYCSSTOS-UMSONDCASA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[[(3s)-pyrrolidin-3-yl]amino]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N[C@H]1CCNC1 AQZUYEHYCSSTOS-UMSONDCASA-N 0.000 claims 1
- GPXSIDKEQZLUST-SXSPYAJSSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[methyl(oxan-4-yl)amino]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N(C)C1CCOCC1 GPXSIDKEQZLUST-SXSPYAJSSA-N 0.000 claims 1
- MGQHBEKIVYECCS-DUXKGJEZSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[methyl(propan-2-yl)amino]propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CN(C)C(C)C)=CC=C(Cl)C=C1 MGQHBEKIVYECCS-DUXKGJEZSA-N 0.000 claims 1
- SEOVPDGEKCGNRW-DUXKGJEZSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-piperazin-1-ylpropan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCNCC1 SEOVPDGEKCGNRW-DUXKGJEZSA-N 0.000 claims 1
- VWFHPQXIADBYRU-DUXKGJEZSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-thiomorpholin-4-ylpropan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCSCC1 VWFHPQXIADBYRU-DUXKGJEZSA-N 0.000 claims 1
- GRZXWCHAXNAUHY-AHRSYUTCSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C=C1 GRZXWCHAXNAUHY-AHRSYUTCSA-N 0.000 claims 1
- ZAPKSMBFGRLTBZ-OTNPHJDUSA-N (2s)-2-(4-chlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[[(3r)-oxolan-3-yl]amino]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N[C@@H]1CCOC1 ZAPKSMBFGRLTBZ-OTNPHJDUSA-N 0.000 claims 1
- QGUOXJAMLQVZTF-CDHQVMDDSA-N (2s)-2-(4-chlorophenyl)-3-(3-hydroxyazetidin-1-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CC(O)C1 QGUOXJAMLQVZTF-CDHQVMDDSA-N 0.000 claims 1
- XGQBOEHKQAUZEB-UEVCKROQSA-N (2s)-2-(4-chlorophenyl)-3-(4-ethylpiperazin-1-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1CN(CC)CCN1C[C@H](C=1C=CC(Cl)=CC=1)C(=O)N1CCN(C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CC1 XGQBOEHKQAUZEB-UEVCKROQSA-N 0.000 claims 1
- DMFQEDIRMMWZOK-ZPMCFJSWSA-N (2s)-2-(4-chlorophenyl)-3-(4-fluoropiperidin-1-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCC(F)CC1 DMFQEDIRMMWZOK-ZPMCFJSWSA-N 0.000 claims 1
- SBBKNPLQAOQYBE-SXSPYAJSSA-N (2s)-2-(4-chlorophenyl)-3-(cyclohexylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NC1CCCCC1 SBBKNPLQAOQYBE-SXSPYAJSSA-N 0.000 claims 1
- SBBKNPLQAOQYBE-YSZBQJHXSA-N (2s)-2-(4-chlorophenyl)-3-(cyclohexylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NC1CCCCC1 SBBKNPLQAOQYBE-YSZBQJHXSA-N 0.000 claims 1
- DJKIPNZIOLJURK-MAODMQOUSA-N (2s)-2-(4-chlorophenyl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NCC1CC1 DJKIPNZIOLJURK-MAODMQOUSA-N 0.000 claims 1
- DJKIPNZIOLJURK-HBGVWJBISA-N (2s)-2-(4-chlorophenyl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NCC1CC1 DJKIPNZIOLJURK-HBGVWJBISA-N 0.000 claims 1
- XCEGMTIINVNYNX-ATZDWAIDSA-N (2s)-2-(4-chlorophenyl)-3-(dimethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN(C)C)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(Cl)C=C1 XCEGMTIINVNYNX-ATZDWAIDSA-N 0.000 claims 1
- KGJFDXSJMOTVJN-OTDDCGGZSA-N (2s)-2-(4-chlorophenyl)-3-[(3,3-dimethylcyclohexyl)amino]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NC1CCCC(C)(C)C1 KGJFDXSJMOTVJN-OTDDCGGZSA-N 0.000 claims 1
- UKUKRSMZCFAQGY-YJSIEXFISA-N (2s)-2-(4-chlorophenyl)-3-[(3s)-3-(dimethylamino)pyrrolidin-1-yl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CC[C@H](N(C)C)C1 UKUKRSMZCFAQGY-YJSIEXFISA-N 0.000 claims 1
- KEPZFCOIQOGOAI-CTUHWIOQSA-N (2s)-2-(4-chlorophenyl)-3-[(4,4-dimethylcyclohexyl)amino]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)NC1CCC(C)(C)CC1 KEPZFCOIQOGOAI-CTUHWIOQSA-N 0.000 claims 1
- AWFVEFPXVJEZNV-STZQEDGTSA-N (2s)-2-(4-chlorophenyl)-3-[2-hydroxyethyl(propan-2-yl)amino]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CN(CCO)C(C)C)=CC=C(Cl)C=C1 AWFVEFPXVJEZNV-STZQEDGTSA-N 0.000 claims 1
- LHESKSDGVWTWIF-CTUHWIOQSA-N (2s)-2-(4-chlorophenyl)-3-[4-(dimethylamino)piperidin-1-yl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCC(N(C)C)CC1 LHESKSDGVWTWIF-CTUHWIOQSA-N 0.000 claims 1
- CBPFHOOOOIINAJ-KBAYOESNSA-N (2s)-2-(5-bromothiophen-2-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1SC(Br)=CC=1)NC1CCOCC1 CBPFHOOOOIINAJ-KBAYOESNSA-N 0.000 claims 1
- NYYIKRNWSFCJDK-BZUAXINKSA-N (2s)-2-(5-bromothiophen-2-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Br)S1 NYYIKRNWSFCJDK-BZUAXINKSA-N 0.000 claims 1
- CBPFHOOOOIINAJ-NXHRZFHOSA-N (2s)-2-(5-bromothiophen-2-yl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1SC(Br)=CC=1)NC1CCOCC1 CBPFHOOOOIINAJ-NXHRZFHOSA-N 0.000 claims 1
- NYYIKRNWSFCJDK-OAGGEKHMSA-N (2s)-2-(5-bromothiophen-2-yl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Br)S1 NYYIKRNWSFCJDK-OAGGEKHMSA-N 0.000 claims 1
- CQZBIBHQPCYHOO-DJIMGWMZSA-N (2s)-2-(5-bromothiophen-2-yl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1SC(Br)=CC=1)NCC1CC1 CQZBIBHQPCYHOO-DJIMGWMZSA-N 0.000 claims 1
- GJGDNLJWWOESDA-KBAYOESNSA-N (2s)-2-(5-chlorothiophen-2-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1SC(Cl)=CC=1)NC1CCOCC1 GJGDNLJWWOESDA-KBAYOESNSA-N 0.000 claims 1
- BBXCLVDVJJVPOU-BZUAXINKSA-N (2s)-2-(5-chlorothiophen-2-yl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)S1 BBXCLVDVJJVPOU-BZUAXINKSA-N 0.000 claims 1
- GJGDNLJWWOESDA-NXHRZFHOSA-N (2s)-2-(5-chlorothiophen-2-yl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1SC(Cl)=CC=1)NC1CCOCC1 GJGDNLJWWOESDA-NXHRZFHOSA-N 0.000 claims 1
- BBXCLVDVJJVPOU-OAGGEKHMSA-N (2s)-2-(5-chlorothiophen-2-yl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)S1 BBXCLVDVJJVPOU-OAGGEKHMSA-N 0.000 claims 1
- HYAZYJQOAUYZSW-DJIMGWMZSA-N (2s)-2-(5-chlorothiophen-2-yl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1SC(Cl)=CC=1)NCC1CC1 HYAZYJQOAUYZSW-DJIMGWMZSA-N 0.000 claims 1
- HYAZYJQOAUYZSW-OIISXLGYSA-N (2s)-2-(5-chlorothiophen-2-yl)-3-(cyclopropylmethylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1SC(Cl)=CC=1)NCC1CC1 HYAZYJQOAUYZSW-OIISXLGYSA-N 0.000 claims 1
- NOLUQBGMNDMEJW-XFQXTVEOSA-N (2s)-2-[2-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(C(F)(F)F)C=C1F NOLUQBGMNDMEJW-XFQXTVEOSA-N 0.000 claims 1
- XWVOYCYKVHDZAO-OZOXKJRCSA-N (2s)-2-[2-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-[methyl(propan-2-yl)amino]propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CN(C)C(C)C)=CC=C(C(F)(F)F)C=C1F XWVOYCYKVHDZAO-OZOXKJRCSA-N 0.000 claims 1
- PVPUTMAIINVYHH-CNDZOEFASA-N (2s)-2-[2-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C(=CC(=CC=1)C(F)(F)F)F)NC1CCOCC1 PVPUTMAIINVYHH-CNDZOEFASA-N 0.000 claims 1
- NOLUQBGMNDMEJW-ZTNFWEORSA-N (2s)-2-[2-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@H](O)C=3N=CN=2)CNC(C)C)=CC=C(C(F)(F)F)C=C1F NOLUQBGMNDMEJW-ZTNFWEORSA-N 0.000 claims 1
- BHIAOYWMILQADT-SZVBFZGTSA-N (2s)-2-[3-fluoro-4-(trifluoromethoxy)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(OC(F)(F)F)C(F)=C1 BHIAOYWMILQADT-SZVBFZGTSA-N 0.000 claims 1
- ZZPRCGSANDNMBX-BSIFCXSSSA-N (2s)-2-[3-fluoro-4-(trifluoromethoxy)phenyl]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(OC(F)(F)F)=CC=1)NC1CCOCC1 ZZPRCGSANDNMBX-BSIFCXSSSA-N 0.000 claims 1
- HPLLXKZTFYMEBR-WRWLIDTKSA-N (2s)-2-[3-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(C(F)(F)F)C(F)=C1 HPLLXKZTFYMEBR-WRWLIDTKSA-N 0.000 claims 1
- XMGQFGHGCVFDFK-PERKRYKHSA-N (2s)-2-[3-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(oxan-4-ylamino)propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(=CC=1)C(F)(F)F)NC1CCOCC1 XMGQFGHGCVFDFK-PERKRYKHSA-N 0.000 claims 1
- XCUWQXDXHIKEQH-SZVBFZGTSA-N (2s)-2-[4-chloro-3-(trifluoromethoxy)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C(OC(F)(F)F)=C1 XCUWQXDXHIKEQH-SZVBFZGTSA-N 0.000 claims 1
- RRYMJFIXVPYGON-WRWLIDTKSA-N (2s)-2-[4-chloro-3-(trifluoromethyl)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(Cl)C(C(F)(F)F)=C1 RRYMJFIXVPYGON-WRWLIDTKSA-N 0.000 claims 1
- PXNRLWPGIVMVJJ-SZVBFZGTSA-N (2s)-2-[4-fluoro-3-(trifluoromethoxy)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one Chemical compound C1([C@H](C(=O)N2CCN(CC2)C=2C=3[C@H](C)C[C@@H](O)C=3N=CN=2)CNC(C)C)=CC=C(F)C(OC(F)(F)F)=C1 PXNRLWPGIVMVJJ-SZVBFZGTSA-N 0.000 claims 1
- XQHJGSRNSFPVKJ-ZPMCFJSWSA-N (2s)-3-(4-aminopiperidin-1-yl)-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(Cl)=CC=1)N1CCC(N)CC1 XQHJGSRNSFPVKJ-ZPMCFJSWSA-N 0.000 claims 1
- RRSHYJAMIPDULM-MAODMQOUSA-N (2s)-3-(cyclopropylmethylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C=CC(=CC=1)C(F)(F)F)NCC1CC1 RRSHYJAMIPDULM-MAODMQOUSA-N 0.000 claims 1
- RRSHYJAMIPDULM-HBGVWJBISA-N (2s)-3-(cyclopropylmethylamino)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=CC(=CC=1)C(F)(F)F)NCC1CC1 RRSHYJAMIPDULM-HBGVWJBISA-N 0.000 claims 1
- XGFQLCBCUUZIGA-QFIXIFRTSA-N (2s)-3-(cyclopropylmethylamino)-2-[2-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@H](O)C[C@H](C=12)C)C=1C(=CC(=CC=1)C(F)(F)F)F)NCC1CC1 XGFQLCBCUUZIGA-QFIXIFRTSA-N 0.000 claims 1
- ZLQWIDSPRZYJTH-ZTNFWEORSA-N (2s)-3-(cyclopropylmethylamino)-2-[3-fluoro-4-(trifluoromethoxy)phenyl]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(OC(F)(F)F)=CC=1)NCC1CC1 ZLQWIDSPRZYJTH-ZTNFWEORSA-N 0.000 claims 1
- NRRILVLCPJUGCY-FPDPHYFHSA-N (2s)-3-(cyclopropylmethylamino)-2-[3-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C([C@@H](C(=O)N1CCN(CC1)C=1N=CN=C2[C@@H](O)C[C@H](C=12)C)C=1C=C(F)C(=CC=1)C(F)(F)F)NCC1CC1 NRRILVLCPJUGCY-FPDPHYFHSA-N 0.000 claims 1
- LWLIQAMPIZQDEE-NSISKUIASA-N (2s)-3-(tert-butylamino)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]propan-1-one Chemical compound C1([C@@H](CNC(C)(C)C)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(C(F)(F)F)C=C1 LWLIQAMPIZQDEE-NSISKUIASA-N 0.000 claims 1
- MOFXCWWIQFLBCN-SUYBPPKGSA-N (2s)-3-amino-2-(3,4-dichlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(Cl)C(Cl)=C1 MOFXCWWIQFLBCN-SUYBPPKGSA-N 0.000 claims 1
- MOFXCWWIQFLBCN-MRRJBJDNSA-N (2s)-3-amino-2-(3,4-dichlorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@@H](O)C[C@H](C=23)C)=CC=C(Cl)C(Cl)=C1 MOFXCWWIQFLBCN-MRRJBJDNSA-N 0.000 claims 1
- SWPJXSPCNDYNLD-SRCQZFHVSA-N (2s)-3-amino-2-(4-bromo-2-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(Br)C=C1F SWPJXSPCNDYNLD-SRCQZFHVSA-N 0.000 claims 1
- SWPJXSPCNDYNLD-VMGRFDJRSA-N (2s)-3-amino-2-(4-bromo-2-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@@H](O)C[C@H](C=23)C)=CC=C(Br)C=C1F SWPJXSPCNDYNLD-VMGRFDJRSA-N 0.000 claims 1
- VCNUBMBFFAMLDD-MRRJBJDNSA-N (2s)-3-amino-2-(4-bromo-3-fluorophenyl)-1-[4-[(5r,7s)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@@H](O)C[C@H](C=23)C)=CC=C(Br)C(F)=C1 VCNUBMBFFAMLDD-MRRJBJDNSA-N 0.000 claims 1
- JGWUIBTXPBNBSH-SRCQZFHVSA-N (2s)-3-amino-2-(4-chloro-2-fluorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(Cl)C=C1F JGWUIBTXPBNBSH-SRCQZFHVSA-N 0.000 claims 1
- FKWGZLUCQAOQDJ-KBRIMQKVSA-N (2s)-3-amino-2-(4-chlorophenyl)-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(Cl)C=C1 FKWGZLUCQAOQDJ-KBRIMQKVSA-N 0.000 claims 1
- PDWRQDZWROMPGV-SRCQZFHVSA-N (2s)-3-amino-2-[2-fluoro-4-(trifluoromethyl)phenyl]-1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1([C@@H](CN)C(=O)N2CCN(CC2)C=2N=CN=C3[C@H](O)C[C@H](C=23)C)=CC=C(C(F)(F)F)C=C1F PDWRQDZWROMPGV-SRCQZFHVSA-N 0.000 claims 1
- AUFBJPAYMXKDIC-GHMZBOCLSA-N 1-[4-[(5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]propan-1-one Chemical compound C1CN(C(=O)CC)CCN1C1=NC=NC2=C1[C@H](C)C[C@H]2O AUFBJPAYMXKDIC-GHMZBOCLSA-N 0.000 claims 1
- 125000004188 dichlorophenyl group Chemical group 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 238000013160 medical therapy Methods 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 0 CC(C)(C(*)(*)C(C)=O)N(*)* Chemical compound CC(C)(C(*)(*)C(C)=O)N(*)* 0.000 description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BAYGVMXZJBFEMB-UHFFFAOYSA-N 4-(trifluoromethyl)phenol Chemical compound OC1=CC=C(C(F)(F)F)C=C1 BAYGVMXZJBFEMB-UHFFFAOYSA-N 0.000 description 1
- XMNHYTVFSORYKH-UHFFFAOYSA-N CC(C(CC1(CC1)N(C)C)c(cc1)ccc1Cl)=O Chemical compound CC(C(CC1(CC1)N(C)C)c(cc1)ccc1Cl)=O XMNHYTVFSORYKH-UHFFFAOYSA-N 0.000 description 1
- AFNNDFNFOMRPSI-UHFFFAOYSA-N CC(C(CC1(CC1)N)c(cc1)ccc1Cl)=O Chemical compound CC(C(CC1(CC1)N)c(cc1)ccc1Cl)=O AFNNDFNFOMRPSI-UHFFFAOYSA-N 0.000 description 1
- GIRPDUISSCBOAW-UHFFFAOYSA-N CC(C)(CC(C(C(C)=C)=O)c(cc1)cc(F)c1Cl)N Chemical compound CC(C)(CC(C(C(C)=C)=O)c(cc1)cc(F)c1Cl)N GIRPDUISSCBOAW-UHFFFAOYSA-N 0.000 description 1
- STHHIRBHSKKCFW-JTQLQIEISA-N CC(C)(C[C@@H](C(C)=O)c(cc1)cc(F)c1Cl)N Chemical compound CC(C)(C[C@@H](C(C)=O)c(cc1)cc(F)c1Cl)N STHHIRBHSKKCFW-JTQLQIEISA-N 0.000 description 1
- BIEGKMIHRQBEGD-UHFFFAOYSA-N CC(C)C(C(C)(CCN)c(cc1)ccc1Cl)=O Chemical compound CC(C)C(C(C)(CCN)c(cc1)ccc1Cl)=O BIEGKMIHRQBEGD-UHFFFAOYSA-N 0.000 description 1
- IAUNSZQZDQBJKM-UHFFFAOYSA-N CC(C)C(C1(Cc(cc2)ccc2Cl)CC1)=O Chemical compound CC(C)C(C1(Cc(cc2)ccc2Cl)CC1)=O IAUNSZQZDQBJKM-UHFFFAOYSA-N 0.000 description 1
- CVZKETBJZSOJLN-UHFFFAOYSA-N CC(C)C(CC1)CN1C(C)=O Chemical compound CC(C)C(CC1)CN1C(C)=O CVZKETBJZSOJLN-UHFFFAOYSA-N 0.000 description 1
- GOWKHWWLCQGSAA-UHFFFAOYSA-N CC(C1(Cc(cc2)ccc2Cl)CC1)=O Chemical compound CC(C1(Cc(cc2)ccc2Cl)CC1)=O GOWKHWWLCQGSAA-UHFFFAOYSA-N 0.000 description 1
- DWPMJTVAEDBIES-UHFFFAOYSA-N CC(CC1)CCN1C(C)=O Chemical compound CC(CC1)CCN1C(C)=O DWPMJTVAEDBIES-UHFFFAOYSA-N 0.000 description 1
- WYBMRSHREKQGOJ-PKHIMPSTSA-N CC(CCCN1CCOCC1)[C@H](Cc(cc1)ccc1Cl)C(NC)=O Chemical compound CC(CCCN1CCOCC1)[C@H](Cc(cc1)ccc1Cl)C(NC)=O WYBMRSHREKQGOJ-PKHIMPSTSA-N 0.000 description 1
- DSDWHIYMWZAVNP-UHFFFAOYSA-N CC(N(CC1)CC1[IH]I)=O Chemical compound CC(N(CC1)CC1[IH]I)=O DSDWHIYMWZAVNP-UHFFFAOYSA-N 0.000 description 1
- YRPDCERXKOLAFN-UHFFFAOYSA-N CCC(CC1)CCN1C(C)=O Chemical compound CCC(CC1)CCN1C(C)=O YRPDCERXKOLAFN-UHFFFAOYSA-N 0.000 description 1
- JADJDUSHBTYYNQ-UHFFFAOYSA-N CN(C)CCCC(N(C)C)=O Chemical compound CN(C)CCCC(N(C)C)=O JADJDUSHBTYYNQ-UHFFFAOYSA-N 0.000 description 1
- IJVQAJHYYRVZNE-UHFFFAOYSA-N CN(C1)CC1O Chemical compound CN(C1)CC1O IJVQAJHYYRVZNE-UHFFFAOYSA-N 0.000 description 1
- KKNMPQDGUAQJJC-UHFFFAOYSA-N C[I](C)c([s]1)ccc1Br Chemical compound C[I](C)c([s]1)ccc1Br KKNMPQDGUAQJJC-UHFFFAOYSA-N 0.000 description 1
- JSMMZMYGEVUURX-UHFFFAOYSA-N Cc([s]1)ccc1Cl Chemical compound Cc([s]1)ccc1Cl JSMMZMYGEVUURX-UHFFFAOYSA-N 0.000 description 1
- OFKWIQJLYCKDNY-UHFFFAOYSA-N Cc(nc1)ccc1Br Chemical compound Cc(nc1)ccc1Br OFKWIQJLYCKDNY-UHFFFAOYSA-N 0.000 description 1
- IPBPLHNLRKRLPJ-UHFFFAOYSA-N NCC1CCOCC1 Chemical compound NCC1CCOCC1 IPBPLHNLRKRLPJ-UHFFFAOYSA-N 0.000 description 1
- COBSNIZQNVIMGY-UHFFFAOYSA-N O=C(C1CC1)C1(Cc(cc2)ccc2Cl)C2(CC3CCOCC3)C1C2 Chemical compound O=C(C1CC1)C1(Cc(cc2)ccc2Cl)C2(CC3CCOCC3)C1C2 COBSNIZQNVIMGY-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81871806P | 2006-07-06 | 2006-07-06 | |
| US60/818,718 | 2006-07-06 | ||
| PCT/US2007/072885 WO2008006040A1 (en) | 2006-07-06 | 2007-07-05 | Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013029956A Division JP5836294B2 (ja) | 2006-07-06 | 2013-02-19 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009542723A JP2009542723A (ja) | 2009-12-03 |
| JP2009542723A5 true JP2009542723A5 (enExample) | 2010-08-26 |
| JP5266216B2 JP5266216B2 (ja) | 2013-08-21 |
Family
ID=38686743
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009518636A Active JP5266216B2 (ja) | 2006-07-06 | 2007-07-05 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
| JP2013029956A Active JP5836294B2 (ja) | 2006-07-06 | 2013-02-19 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
| JP2013133983A Pending JP2013177470A (ja) | 2006-07-06 | 2013-06-26 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
| JP2014188238A Withdrawn JP2014231530A (ja) | 2006-07-06 | 2014-09-16 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013029956A Active JP5836294B2 (ja) | 2006-07-06 | 2013-02-19 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
| JP2013133983A Pending JP2013177470A (ja) | 2006-07-06 | 2013-06-26 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
| JP2014188238A Withdrawn JP2014231530A (ja) | 2006-07-06 | 2014-09-16 | Ａｋｔプロテインキナーゼ阻害剤としてのヒドロキシル化およびメトキシル化されたシクロペンタ［ｄ］ピリミジン |
Country Status (34)
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA95641C2 (xx) * | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы |
| US8063050B2 (en) * | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| WO2008006039A1 (en) | 2006-07-06 | 2008-01-10 | Array Biopharma Inc. | Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| DE602007011628D1 (de) * | 2006-07-06 | 2011-02-10 | Array Biopharma Inc | Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren |
| RU2481336C2 (ru) | 2006-07-06 | 2013-05-10 | Эррэй Биофарма Инк. | Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт |
| US20110135569A1 (en) | 2007-03-20 | 2011-06-09 | Peak Biosciences Inc. | Method for therapeutic administration of radionucleosides |
| US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
| MX2009014013A (es) | 2007-07-05 | 2010-01-28 | Array Biopharma Inc | Pirimidil ciclopentanos como inhibidores de la proteina cinasa akt. |
| US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| CA2692502C (en) | 2007-07-05 | 2016-03-01 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| CN104876921A (zh) | 2008-01-09 | 2015-09-02 | 阵列生物制药公司 | 作为AKT蛋白激酶抑制剂的5H-环戊二烯并[d]嘧啶 |
| US8853216B2 (en) * | 2008-01-09 | 2014-10-07 | Array Biopharma, Inc. | Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor |
| US8835434B2 (en) * | 2008-01-09 | 2014-09-16 | Array Biopharma, Inc. | Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| TW200940542A (en) | 2008-01-09 | 2009-10-01 | Array Biopharma Inc | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| EP2655619A4 (en) * | 2010-12-23 | 2014-10-22 | Genentech Inc | COMBINATION THERAPY FROM AUTOPHAGIA AND HEMMER FOR THE TREATMENT OF NEOPLASMS |
| FI2694072T4 (fi) * | 2011-04-01 | 2024-09-30 | Genentech Inc | Akt-inhibiittoriyhdisteen ja abirateronin yhdistelmä käytettäväksi terapeuttisissa hoidoissa |
| TR201815685T4 (tr) | 2011-04-01 | 2018-11-21 | Genentech Inc | Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları. |
| SG194050A1 (en) * | 2011-04-01 | 2013-11-29 | Genentech Inc | Biomarkers for predicting sensitivity to cancer treatments |
| ES2588878T3 (es) * | 2012-05-17 | 2016-11-07 | Array Biopharma, Inc. | Proceso para preparar compuestos de ciclopentilpirimidina hidroxilada |
| LT2858989T (lt) * | 2012-05-17 | 2020-08-10 | Genentech, Inc. | Akt inhibuojančio pirimidinil-ciklopentano junginio amorfinė forma, jo kompozicijos ir būdai |
| EP2850200A1 (en) | 2012-05-17 | 2015-03-25 | Genentech, Inc. | Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof |
| BR112014028585B1 (pt) | 2012-05-17 | 2020-12-22 | Genentech , Inc | processo para fabricação de aminoácidos, e seus intermediários |
| ES2582557T3 (es) * | 2012-05-17 | 2016-09-13 | Array Biopharma, Inc. | Proceso para la preparación de compuestos hidroxilados de ciclopentilpirimidina |
| WO2014068070A1 (en) | 2012-10-31 | 2014-05-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for preventing antiphospholipid syndrome (aps) |
| MX2015007054A (es) | 2012-12-07 | 2016-01-12 | Gen Hospital Corp | Combinaciones de un compuesto inhibidor de pi3k/akt con un compuesto inhibidor de her3/egfr, y métodos de uso. |
| JP6340162B2 (ja) * | 2012-12-20 | 2018-06-06 | 日東電工株式会社 | アポトーシス誘導剤 |
| CN112898210B (zh) | 2013-11-15 | 2025-02-21 | 豪夫迈·罗氏有限公司 | 用于制备嘧啶基环戊烷化合物的方法 |
| PL3197875T3 (pl) | 2014-09-26 | 2020-03-31 | F. Hoffmann-La Roche Ag | Sposoby wytwarzania związków (cyklopentylo[d]pirymidyn-4-ylo)piperazynowych |
| CN109789141B (zh) | 2016-08-10 | 2022-08-26 | 豪夫迈·罗氏有限公司 | 包含Akt蛋白激酶抑制剂的药物组合物 |
| MX2019004950A (es) | 2016-10-28 | 2019-09-26 | Icahn School Med Mount Sinai | Composiciones y metodos para tratar el cancer mediado por el potenciador del homologo zeste 2. |
| JP2021515013A (ja) * | 2018-03-06 | 2021-06-17 | アイカーン スクール オブ メディスン アット マウント シナイ | セリンスレオニンキナーゼ（ａｋｔ）分解／破壊化合物および使用方法 |
| JP2021527666A (ja) | 2018-06-21 | 2021-10-14 | アイカーン スクール オブ メディスン アット マウント シナイ | Ｗｄ４０反復ドメインタンパク質５（ｗｄｒ５）分解／破壊化合物および使用の方法 |
| WO2020010204A1 (en) | 2018-07-05 | 2020-01-09 | Icahn School Of Medicine At Mount Sinai | Protein tyrosine kinase 6 (ptk6) degradation / disruption compounds and methods of use |
| EP3897612A1 (en) | 2018-12-19 | 2021-10-27 | Genentech, Inc. | Treatment of breast cancer using combination therapies comprising an akt inhibitor, a taxane, and a pd-l1 inhibitor |
| BR112021011894A2 (pt) | 2018-12-21 | 2021-09-08 | Daiichi Sankyo Company, Limited | Composição farmacêutica |
| US12617784B2 (en) | 2019-01-29 | 2026-05-05 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | AKT inhibitor |
| WO2020201073A1 (en) | 2019-03-29 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of keloid, hypertrophic scars and/or hyperpigmentation disorders |
| JP7667742B2 (ja) | 2019-04-09 | 2025-04-23 | ダナ－ファーバー キャンサー インスティテュート，インコーポレイテッド | Ａｔｐ競合性ａｋｔ阻害剤ｇｄｃ－００６８とｅ３リガーゼリガンドとの結合によるａｋｔの分解および使用方法 |
| CN114423463B (zh) | 2019-05-06 | 2025-09-26 | 西奈山伊坎医学院 | 作为hpk1的降解剂的异双功能化合物 |
| JP2023520140A (ja) * | 2020-03-17 | 2023-05-16 | 江蘇恒瑞医薬股▲ふん▼有限公司 | 縮合二環系誘導体、その調製方法及びその医薬的応用 |
| US12103924B2 (en) | 2020-06-01 | 2024-10-01 | Icahn School Of Medicine At Mount Sinai | Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use |
| CN120887837A (zh) | 2020-06-16 | 2025-11-04 | 豪夫迈·罗氏有限公司 | 用于制备羟基化环戊基嘧啶化合物的方法 |
| US12673061B2 (en) | 2020-07-22 | 2026-07-07 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Unit dosage composition of AKT inhibitor |
| EP4186902A4 (en) | 2020-07-22 | 2024-06-05 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | DIHYDROPYRIDO[2,3-D]PYRIMIDINONE DERIVATIVE SALT, PREPARATION METHOD AND USE THEREOF |
| TWI750905B (zh) * | 2020-11-19 | 2021-12-21 | 財團法人國家衛生研究院 | 噻唑化合物作為蛋白質激酶抑制劑 |
| KR102689151B1 (ko) * | 2021-09-06 | 2024-07-29 | 연세대학교 산학협력단 | Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물 |
| WO2023043869A1 (en) * | 2021-09-15 | 2023-03-23 | Teva Pharmaceuticals International Gmbh | Solid state forms of ipatasertib citrate |
| CN113788834B (zh) * | 2021-09-18 | 2022-11-29 | 河南奥思恩医药科技有限公司 | 2,4-二氯-6,7-二氢-5H-吡咯并[3,4-d]嘧啶盐酸盐的制备方法 |
| WO2023109540A1 (zh) * | 2021-12-17 | 2023-06-22 | 中国医药研究开发中心有限公司 | 具有akt激酶抑制活性的杂环化合物及其制备方法和医药用途 |
| CN119278041A (zh) | 2022-03-31 | 2025-01-07 | 阿斯利康(瑞典)有限公司 | 用于治疗癌症的与akt抑制剂组合的表皮生长因子受体（egfr）酪氨酸激酶抑制剂 |
| WO2024083716A1 (en) | 2022-10-17 | 2024-04-25 | Astrazeneca Ab | Combinations of a serd for the treatment of cancer |
| JP2025539034A (ja) | 2022-11-11 | 2025-12-03 | アストラゼネカ・アクチエボラーグ | 癌の治療のための併用療法 |
| WO2024160843A1 (en) | 2023-01-31 | 2024-08-08 | F. Hoffmann-La Roche Ag | Mutant ketoreductase with increased ketoreductase activity as well as methods and uses involving the same |
| EP4643858A1 (en) | 2024-04-29 | 2025-11-05 | Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical composition for the treatment of uterine disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| NL7112938A (enExample) * | 1970-09-30 | 1972-04-05 | ||
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| WO1998030546A1 (en) * | 1997-01-08 | 1998-07-16 | F. Hoffmann-La Roche Ag | TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES |
| ES2152902B1 (es) * | 1999-07-27 | 2001-08-16 | Medichem Sa | Procedimiento de obtencion de venlafaxina |
| HU228668B1 (hu) * | 2000-08-18 | 2013-05-28 | Millennium Pharmaceuticals | Kináz inhibitor kinazolin-származékok és az ezeket tartalmazó gyógyszerkészítmények |
| AU2001290912A1 (en) * | 2000-09-15 | 2002-03-26 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| CA2443135C (en) * | 2001-03-30 | 2010-07-13 | Allan R. Moorman | Pharmaceutically active compounds and methods of use |
| ATE424388T1 (de) * | 2001-12-06 | 2009-03-15 | Merck & Co Inc | Mitotische kinesinhemmer |
| MXPA04007191A (es) * | 2002-01-23 | 2005-03-31 | Bayer Pharmaceuticals Corp | Derivados de pirimidina como inhibidores de rho-quinasa. |
| TW200306819A (en) * | 2002-01-25 | 2003-12-01 | Vertex Pharma | Indazole compounds useful as protein kinase inhibitors |
| AU2004293026B2 (en) * | 2003-11-21 | 2012-01-19 | Array Biopharma Inc. | AKT protein kinase inhibitors |
| EP1751133B1 (en) * | 2004-04-28 | 2010-04-14 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
| WO2005113762A1 (en) | 2004-05-18 | 2005-12-01 | Pfizer Products Inc. | CRYSTAL STRUCTURE OF PROTEIN KINASE B-α (AKT-1) AND USES THEREOF |
| JP2008538102A (ja) * | 2005-03-03 | 2008-10-09 | ザ バーナム インスティテュート フォー メディカル リサーチ | バーチャルドッキングアプローチを適用したプロテインキナーゼｂ阻害剤のスクリーニング方法並びにそれにより見出された化合物及び組成物 |
| WO2008006039A1 (en) * | 2006-07-06 | 2008-01-10 | Array Biopharma Inc. | Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| UA95641C2 (xx) * | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы |
| RU2481336C2 (ru) * | 2006-07-06 | 2013-05-10 | Эррэй Биофарма Инк. | Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт |
-
2007
- 2007-05-07 UA UAA200900764A patent/UA95641C2/ru unknown
- 2007-07-05 SI SI200731699T patent/SI2402325T1/sl unknown
- 2007-07-05 SG SG2012082871A patent/SG185980A1/en unknown
- 2007-07-05 NZ NZ610633A patent/NZ610633A/en unknown
- 2007-07-05 EP EP11166123.7A patent/EP2399909B1/en active Active
- 2007-07-05 IN IN2886KON2014 patent/IN2014KN02886A/en unknown
- 2007-07-05 MY MYPI20090024A patent/MY147364A/en unknown
- 2007-07-05 NZ NZ597647A patent/NZ597647A/xx unknown
- 2007-07-05 SI SI200730780T patent/SI2049501T1/sl unknown
- 2007-07-05 AU AU2007269060A patent/AU2007269060B2/en active Active
- 2007-07-05 BR BRPI0713923A patent/BRPI0713923B8/pt active IP Right Grant
- 2007-07-05 SG SG2012063863A patent/SG184706A1/en unknown
- 2007-07-05 MX MX2019008117A patent/MX377920B/es unknown
- 2007-07-05 SG SG2013019468A patent/SG188905A1/en unknown
- 2007-07-05 BR BR122013028012A patent/BR122013028012B8/pt active IP Right Grant
- 2007-07-05 CN CN2012101841274A patent/CN102816124A/zh active Pending
- 2007-07-05 PL PL07799337T patent/PL2049501T3/pl unknown
- 2007-07-05 RU RU2009103900/04A patent/RU2478632C2/ru active
- 2007-07-05 KR KR1020137031899A patent/KR101578877B1/ko active Active
- 2007-07-05 CA CA2836316A patent/CA2836316A1/en not_active Abandoned
- 2007-07-05 ES ES07799337T patent/ES2372774T3/es active Active
- 2007-07-05 PL PL11166125T patent/PL2402325T3/pl unknown
- 2007-07-05 HU HUE11166125A patent/HUE026237T2/en unknown
- 2007-07-05 ES ES11166125.2T patent/ES2554252T3/es active Active
- 2007-07-05 KR KR1020127011042A patent/KR101495408B1/ko active Active
- 2007-07-05 KR KR1020097002395A patent/KR101178672B1/ko active Active
- 2007-07-05 WO PCT/US2007/072885 patent/WO2008006040A1/en not_active Ceased
- 2007-07-05 MX MX2015013326A patent/MX366319B/es unknown
- 2007-07-05 JP JP2009518636A patent/JP5266216B2/ja active Active
- 2007-07-05 SG SG10201802127UA patent/SG10201802127UA/en unknown
- 2007-07-05 KR KR1020147017714A patent/KR20140093291A/ko not_active Ceased
- 2007-07-05 BR BR122013028005A patent/BR122013028005B8/pt active IP Right Grant
- 2007-07-05 MX MX2008016202A patent/MX2008016202A/es active IP Right Grant
- 2007-07-05 ES ES11166123.7T patent/ES2554228T3/es active Active
- 2007-07-05 AT AT07799337T patent/ATE524447T1/de active
- 2007-07-05 NZ NZ573732A patent/NZ573732A/en unknown
- 2007-07-05 DK DK11166125.2T patent/DK2402325T3/en active
- 2007-07-05 EP EP07799337A patent/EP2049501B1/en active Active
- 2007-07-05 DK DK07799337.6T patent/DK2049501T3/da active
- 2007-07-05 CA CA2656622A patent/CA2656622C/en active Active
- 2007-07-05 EP EP15178003.8A patent/EP2966065A3/en not_active Withdrawn
- 2007-07-05 EP EP11166125.2A patent/EP2402325B1/en active Active
- 2007-07-05 PT PT07799337T patent/PT2049501E/pt unknown
- 2007-07-05 CN CN2007800330851A patent/CN101578273B/zh active Active
- 2007-07-05 HR HR20110908T patent/HRP20110908T1/hr unknown
- 2007-07-05 KR KR1020157010625A patent/KR20150051240A/ko not_active Ceased
- 2007-07-05 RS RS20110551A patent/RS52212B/sr unknown
- 2007-07-06 CL CL200701993A patent/CL2007001993A1/es unknown
- 2007-07-06 TW TW096124780A patent/TWI402266B/zh active
- 2007-07-06 TW TW102117449A patent/TW201332994A/zh unknown
- 2007-07-06 AR ARP070103033A patent/AR061842A1/es not_active Application Discontinuation
-
2008
- 2008-12-17 MX MX2011010569A patent/MX337843B/es unknown
- 2008-12-18 IL IL196028A patent/IL196028A/en active IP Right Grant
-
2009
- 2009-01-05 ZA ZA200900070A patent/ZA200900070B/xx unknown
- 2009-02-03 MA MA31609A patent/MA31655B1/fr unknown
- 2009-02-04 CO CO09010508A patent/CO6150161A2/es unknown
- 2009-02-05 CR CR10600A patent/CR10600A/es unknown
- 2009-02-05 NO NO20090581A patent/NO342346B1/no unknown
-
2011
- 2011-12-08 CY CY20111101222T patent/CY1112117T1/el unknown
-
2012
- 2012-12-20 RU RU2012155606/04A patent/RU2012155606A/ru not_active Application Discontinuation
-
2013
- 2013-02-19 JP JP2013029956A patent/JP5836294B2/ja active Active
- 2013-06-26 JP JP2013133983A patent/JP2013177470A/ja active Pending
- 2013-12-05 AR ARP130104510A patent/AR093810A2/es unknown
-
2014
- 2014-09-16 JP JP2014188238A patent/JP2014231530A/ja not_active Withdrawn
-
2015
- 2015-09-20 IL IL241705A patent/IL241705A0/en unknown
-
2017
- 2017-08-25 AR ARP170102366A patent/AR109424A2/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2478632C2 (ru) | Гидроксилированные и метоксилированные циклопента[d]пиримидины в качестве ингибиторов акт протеинкиназ | |
| JP2009542720A5 (enExample) | ||
| JP2009542722A5 (enExample) | ||
| JP2009542721A5 (enExample) | ||
| AP1122A (en) | Therapeutically active compounds based on based on based on indazole bioisostere replacement of catechol in PDE4 inhibitors. | |
| CA2731146C (en) | 3,4-diarylpyrazoles as protein kinase inhibitors | |
| JP2023514872A5 (enExample) | ||
| CN104039798B (zh) | 具有蛋白激酶抑制活性的噻吩并[3，2-d]嘧啶衍生物 | |
| RU2359967C2 (ru) | Производные тиофена и фармацевтическая композиция (варианты) | |
| JP2010533715A5 (enExample) | ||
| EA005373B1 (ru) | Производные 3(5)-аминопиразола, способ их получения и их применение в качестве противоопухолевых средств | |
| RU2009103899A (ru) | Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ | |
| JP2022520448A5 (enExample) | ||
| AU2014233414B2 (en) | N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2022520811A5 (enExample) | ||
| JP2019537571A5 (enExample) | ||
| WO2014181287A1 (en) | Heterocyclyl compounds and uses thereof | |
| RU2017139727A (ru) | Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования | |
| CN102112463A (zh) | 5-取代的异二氢吲哚化合物 | |
| JP2017525757A5 (enExample) | ||
| RU2005137403A (ru) | Новые замещенные 3-сера-индолы | |
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| CA2449544A1 (en) | Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs | |
| JP2010532387A5 (enExample) | ||
| RU2006145205A (ru) | Терапевтические соединения: пиридин в качестве каркаса |